Gonococcal antimicrobial susceptibility surveillance in Europe, 2016
The surveillance of Neisseria gonorrhoeae antimicrobial susceptibility in the European Union/European Economic Area (EU/EEA) has been co-ordinated by ECDC since 2009. This surveillance is essential for detecting emerging and increasing antimicrobial resistance and making quality-assured data available to inform treatment guidelines.
ECDC country visit to Belgium to discuss antimicrobial resistance issues
An ECDC country visit team conducted an assessment mission on 20-24 November 2017 to discuss antimicrobial resistance (AMR) issues in Belgium with the overall objective to provide an observation-based assessment of the situation in Belgium regarding prevention and control of AMR through prudent use of antibiotics and infection control.
Carbapenemase-producing (OXA-48) Klebsiella pneumoniae ST392 found in travellers previously hospitalised in Gran Canaria, Spain
Thirteen patients with OXA-48-producing Klebsiella pneumoniae ST392 have been reported by Sweden and Norway between January and April 2018 - all returning travellers with prior hospital admission in Gran Canaria. Whole genome sequencing showed tight clustering between the bacterial isolates from the cases.
Rapid risk assessment: Carbapenemase-producing (OXA-48) Klebsiella pneumoniae ST392 in travellers previously hospitalised in Gran Canaria, Spain
This rapid risk assessment evaluates the risk of transmission and further spread of OXA-48-producing Klebsiella pneumonia e ST392 from travellers having sought medical care in Gran Canaria to healthcare facilities in their country of origin in the EU/EEA.
Antimicrobial resistance (EARS-Net) - Annual Epidemiological Report for 2014
Over the last four years (2011 to 2014), the percentages of Klebsiella pneumonia e resistant to fluoroquinolones, third-generation cephalosporins and aminoglycosides, as well as combined resistance to all three antimicrobial groups, has increased significantly at the EU/EEA level.
ECDC country visit to Romania to discuss antimicrobial resistance issues
An ECDC team conducted visits and meetings to discuss AMR issues in Romania with the overall objective of providing an evidence-based assessment of the situation in Romania regarding prevention and control of AMR through prudent use of antibiotics and infection control.
Rapid risk assessment: Emergence of resistance to ceftazidime-avibactam in carbapenem-resistant Enterobacteriaceae
This risk assessment will discuss CAZ-AVI resistance in brief, review the recent literature reporting resistance of CRE to CAZ-AVI, and assess the risk for the EU/EEA countries.
Rapid risk assessment: Carbapenem-resistant Enterobacteriaceae - first update
This update of the 2016 ECDC Rapid Risk Assessment on carbapenem-resistant Enterobacteriaceae (CRE) evaluates the risk for patients and healthcare systems in EU/EEA countries due to the global spread of CRE.
Communicable Disease Threats Report, 27 May - 2 June 2018, week 22
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period 27 May - 2 June 2018 and includes updates on dengue, ebola virus disease, yellow fever, Cholera, monitoring environmental suitability of Vibrio growth in the Baltic Sea, Nipah virus disease, West Nile virus, Salmonella Agona, Rapid emergence of resistance to new antibiotic. β-lactamase inhibitor combination Ceftazidime-Avibactam.
Rapid risk assessment: Candida auris in healthcare settings – Europe
This rapid risk assessment update appraises the risk for spread of C. auris in hospitals in the European Union and European Economic Area (EU/EEA) countries